Welcome to our dedicated page for Sempra Energy SEC filings (Ticker: SRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sempra (NYSE: SRE) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information about Sempra’s financial results, capital structure, regulatory developments and major transactions affecting its utilities and energy infrastructure businesses.
Recent Forms 8-K show how Sempra reports quarterly and year-to-date earnings, including segment data for its California utilities, Texas operations and infrastructure platforms. Other 8-K filings describe material events such as public offerings of junior subordinated notes, updates on wildfire-related legislation in California, and the creation of new regulatory mechanisms in Texas like the unified tracker mechanism for Oncor Electric Delivery Company LLC. Filings also document board and executive changes, proposed decisions from the California Public Utilities Commission, and the structure of large transactions such as the planned sale of a 45% equity interest in Sempra Infrastructure Partners to a KKR-led consortium.
Investors can use these SEC documents to understand Sempra’s capital plans, risk factors, regulatory exposure and financing activities. Forms 8-K complement the company’s periodic reports by providing timely updates on specific events, including debt offerings, dividend-related actions and final investment decisions for LNG projects such as Port Arthur LNG Phase 2. Stock Titan enhances this information with AI-powered tools that help summarize complex filings and highlight important items, so readers can quickly identify sections related to earnings, regulatory matters, capital expenditures or corporate governance.
For users researching SRE, this page serves as a centralized view of Sempra’s official SEC communications, allowing comparison across multiple filings and tracking of how the company’s strategy and regulatory environment evolve over time.
Sempra director Jack T. Taylor reported receiving additional phantom shares of Sempra common stock as part of his director compensation. On 01/02/2026, he acquired 139.34 phantom shares, with the derivative security priced at $89.71 per share. Each phantom share is convertible into one share of Sempra common stock.
After this transaction, Taylor beneficially owned 41,236.46 phantom shares in total. This amount includes 1,892.82 unvested restricted phantom shares that could be forfeited if his service as a director ends before vesting for reasons other than death, disability, or removal without cause.
Kevin C. Sagara, a director of Sempra, reported changes in his deferred equity-based compensation on a Form 4. The filing details phantom shares of Sempra common stock held under the company’s deferred compensation and director compensation programs.
On 01/02/2026, phantom share transactions were reported at prices of $88.95 and $89.71 per share, each representing a right tied on a 1-for-1 basis to Sempra common stock. Following these transactions, Sagara beneficially owned 3,621.32 phantom shares in total.
The phantom shares are payable in cash and may be reallocated into alternative investment accounts. The total includes 2,044.10 unvested restricted phantom shares, which are subject to forfeiture if his service as a director ends before vesting, other than in cases of death, disability, or removal without cause.
Sempra director reports phantom stock compensation
Michael N. Mears, a director of Sempra, reported receiving 139.34 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These derivative securities have a conversion rate of 1-for-1 into Sempra common stock and are immediately exercisable for vested shares, with no stated expiration date.
After this transaction, Mears beneficially owns a total of 20,517.13 phantom shares. This total includes 1,892.82 unvested restricted phantom shares that may be forfeited if his service as a director ends before vesting, except in cases of death, disability, or removal without cause.
Sempra director reports grant of phantom stock units as compensation. Director Richard J. Mark filed a Form 4 showing he acquired 139.34 phantom shares of Sempra common stock on 01/02/2026 as director compensation. These are derivative securities that track the value of Sempra common stock and are convertible into common stock on a 1-for-1 basis. The filing states the phantom shares are immediately exercisable for vested shares and have no expiration date. Following this transaction, Mark beneficially owned 1,717.71 phantom shares, held in direct ownership form.
Sempra director reports phantom stock grant as compensation
Sempra director Jennifer M. Kirk reported receiving 139.34 phantom shares of Sempra common stock on 01/02/2026 as part of her director compensation. These phantom shares are convertible into Sempra common stock on a 1-for-1 basis, with the transaction price noted as $89.71 per share. Following this grant, she beneficially owns a total of 4,672.31 phantom shares.
The total includes 1,892.82 unvested restricted phantom shares that may be forfeited if her service as a director ends before vesting, except in cases of death, disability, or removal without cause. The phantom shares that have vested are immediately exercisable, and no expiration date applies.
Sempra director Pablo A. Ferrero reported receiving derivative equity compensation tied to the company’s common stock. On 01/02/2026, he acquired 139.34 phantom shares of Sempra common stock as director compensation at a price of $89.71 per phantom share.
Each phantom share converts into Sempra common stock on a 1-for-1 basis, and the shares that have vested are immediately exercisable. Following this transaction, Ferrero beneficially owned 15,774.13 phantom shares in total in direct form, with no stated expiration date for these derivative interests.
Sempra director Andres Conesa reported receiving phantom stock as compensation. On 01/02/2026, he acquired 139.34 phantom shares of Sempra common stock as director compensation at a reference price of $89.71 per share. Each phantom share is convertible into one share of Sempra common stock. After this transaction, he beneficially owns 11,310.11 derivative securities in the form of phantom shares, held in direct ownership. The phantom shares are immediately exercisable for vested amounts and have no stated expiration date.
Sempra insider files notice to sell common stock under Rule 144. The filing covers a proposed sale of 30,000 shares of Sempra common stock through Oppenheimer & Co. on the NYSE, with an indicated aggregate market value of $2,648,700. These shares were acquired on 02/19/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan as equity compensation. The filing notes that the person signing the notice represents they are not aware of undisclosed material adverse information about Sempra's current or prospective operations.
Sempra (SRE) Executive VP and CFO Karen L. Sedgwick reported an open-market sale of 7,564 shares of common stock on 11/24/2025. The shares were sold at a weighted average price of $92.29 per share, with individual sale prices ranging from $92.16 to $92.36. After this transaction, she beneficially owned 41,279.57 shares of Sempra common stock directly, and an additional 153.61 shares indirectly through a 401(k) savings plan as of 11/24/2025.
Sempra (SRE) filed a notice under Rule 144 for a planned sale of 7,564 shares of its common stock through Oppenheimer & Co. on the NYSE, with an aggregate market value of $699,670. The filing notes that 652,681,521 shares of Sempra common stock were outstanding. The shares to be sold were acquired via vesting of restricted stock units under Sempra's Long-Term Incentive Plan, including 2,325 shares vested on 01/02/2025, 1,000 shares vested on 01/28/2025, and 4,239 shares vested on 02/19/2025, all received as equity compensation.